Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 79.76%25.97B | 168.17%14.45B | 354.39%5.39B | -191.49%-2.12B | -66.24%2.32B | 15.55%6.86B | -27.82%5.93B | -44.70%8.22B | -17.49%14.87B | -20.08%18.02B |
Net profit before non-cash adjustment | 115.52%28.63B | 168.57%13.29B | 284.87%4.95B | -311.37%-2.68B | -79.14%1.27B | -43.31%6.07B | 35.37%10.71B | -42.83%7.91B | -28.68%13.84B | -5.40%19.4B |
Total adjustment of non-cash items | -84.41%391M | 513.18%2.51B | -293.31%-607M | -88.58%314M | 374.78%2.75B | 120.58%579M | -391.50%-2.81B | 38.45%965M | 200.43%697M | -81.44%232M |
-Depreciation and amortization | 0.05%1.87B | 13.94%1.87B | -8.31%1.64B | -15.27%1.79B | 13.53%2.12B | -4.75%1.86B | 15.33%1.96B | -1.17%1.7B | 9.86%1.72B | 5.11%1.56B |
-Reversal of impairment losses recognized in profit and loss | -69.92%37M | -33.15%123M | -60.85%184M | 264.34%470M | 12.17%129M | -79.93%115M | 1,023.53%573M | -34.62%51M | -76.07%78M | 4,557.14%326M |
-Disposal profit | -265.48%-513M | 113.61%310M | -210.78%-2.28B | -244.29%-733M | 178.40%508M | 87.68%-648M | -849.46%-5.26B | 24.42%-554M | 38.97%-733M | -262.84%-1.2B |
-Other non-cash items | -595.57%-1.01B | 230.13%203M | 87.16%-156M | -40,400.00%-1.22B | 99.60%-3M | -815.85%-751M | 64.04%-82M | 37.36%-228M | 20.00%-364M | -617.05%-455M |
Changes in working capital | -126.85%-3.06B | -229.00%-1.35B | 328.28%1.05B | 114.37%244M | -916.35%-1.7B | 110.61%208M | -201.23%-1.96B | -299.08%-651M | 120.21%327M | -306.11%-1.62B |
-Change in receivables | -151.99%-4.75B | -210.54%-1.89B | -159.34%-607M | 24.45%1.02B | -25.48%822M | 960.58%1.1B | -92.46%104M | -34.80%1.38B | 2.57%2.12B | 238.76%2.06B |
-Change in inventory | -96.03%-1.88B | -185.75%-957M | 402.70%1.12B | 151.03%222M | -96.83%-435M | -327.84%-221M | 638.89%97M | 95.52%-18M | -19.29%-402M | 4.80%-337M |
-Change in payables | 220.16%778M | -81.74%243M | 227.61%1.33B | -167.44%-1.04B | -457.14%-390M | -109.07%-70M | 168.26%772M | -5,755.00%-1.13B | -95.34%20M | 209.16%429M |
-Provision for loans, leases and other losses | 163.13%416M | -378.06%-659M | -9.54%237M | 127.99%262M | -74.63%-936M | 83.13%-536M | -1,937.18%-3.18B | 82.03%-156M | 20.66%-868M | -1,172.55%-1.09B |
-Changes in other current assets | -698.80%-663M | 93.37%-83M | -178.22%-1.25B | -77.87%-450M | -17.13%-253M | -209.09%-216M | 177.04%198M | -317.80%-257M | 163.10%118M | -35.51%-187M |
-Changes in other current liabilities | 52.38%3.04B | 805.91%1.99B | -4.35%220M | 145.45%230M | -441.89%-506M | 221.74%148M | 109.83%46M | 28.66%-468M | 73.67%-656M | -181.57%-2.49B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -4.90%-214M | -36.91%-204M | -11.19%-149M | -27.62%-134M | 0.00%-105M | 37.50%-105M | 19.62%-168M | 15.04%-209M | 20.90%-246M | 11.40%-311M |
Interest received (cash flow from operating activities) | 64.58%1.16B | 61.98%703M | -29.77%434M | -20.87%618M | 9.23%781M | 3.62%715M | 4.55%690M | -2.65%660M | 13.19%678M | 26.91%599M |
Tax refund paid | -38.56%-4.74B | -462.07%-3.42B | 6.74%-609M | 53.22%-653M | 46.29%-1.4B | -3.18%-2.6B | -54.07%-2.52B | 69.06%-1.64B | -36.70%-5.29B | 25.87%-3.87B |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | -761M | 0 | -1M | 0 | -1M | 0 |
Operating cash flow | 92.39%22.17B | 127.59%11.53B | 321.43%5.06B | -374.22%-2.29B | -82.87%834M | 23.68%4.87B | -44.07%3.94B | -29.71%7.04B | -30.66%10.01B | -17.25%14.44B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -187.67%-1.68B | -110.49%-584M | 871.05%5.57B | -112.98%-722M | 45.06%-339M | -110.67%-617M | 885.87%5.78B | 40.11%-736M | -90.54%-1.23B | 53.63%-645M |
Net intangibles purchase and sale | -88.47%-654M | -149.64%-347M | -134.41%-139M | 217.78%404M | -16.27%-343M | 34.44%-295M | -8.96%-450M | 46.64%-413M | -63.64%-774M | ---473M |
Net business purchase and sale | --949M | --0 | -58.09%-713M | ---451M | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 73.95%-311M | 50.10%-1.19B | -135.57%-2.39B | 319.08%6.73B | -58.71%-3.07B | -144.94%-1.94B | -109.72%-790M | 242.82%8.13B | -7.21%-5.69B | 40.46%-5.31B |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---150M | ---- | ---- | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | -44.62%36M | -24.42%65M | 196.55%86M | -40.82%29M | 68.97%49M | 93.33%29M | -11.76%15M | -80.90%17M | -53.40%89M | -85.42%191M |
Dividends received (cash flow from investment activities) | -55.56%8M | -96.89%18M | -46.93%579M | 232.62%1.09B | -17.17%328M | 206.98%396M | --129M | ---- | ---- | ---- |
Net changes in other investments | -4,778.38%-1.81B | 94.61%-37M | -854.17%-687M | 26.53%-72M | 36.36%-98M | 50.64%-154M | -117.96%-312M | 43.67%1.74B | 176.47%1.21B | -553.01%-1.58B |
Investing cash flow | -66.28%-3.46B | -190.39%-2.08B | -67.18%2.3B | 293.35%7.01B | -40.68%-3.62B | -158.87%-2.58B | -49.91%4.38B | 236.54%8.74B | 18.16%-6.4B | 9.63%-7.82B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 40,606.58%30.79B | 99.03%-76M | -202.06%-7.85B | 5,768.70%7.69B | 372.92%131M | 93.97%-48M | -177.96%-796M | 119.30%1.02B | -563.61%-5.29B | -160.46%-797M |
Net common stock issuance | ---10.88B | --0 | --0 | -200.15%-6B | ---2B | --0 | --0 | --0 | -139.56%-6.99B | ---2.92B |
Cash dividends paid | -84.84%-3.43B | -185.96%-1.85B | 61.61%-648M | 33.96%-1.69B | 0.20%-2.56B | 62.27%-2.56B | -0.03%-6.79B | 1.31%-6.79B | 12.79%-6.88B | -62.70%-7.88B |
Net other fund-raising expenses | 1.39%-778M | -28.92%-789M | 29.00%-612M | -51.49%-862M | -28.15%-569M | -18.40%-444M | -8.07%-375M | 19.30%-347M | -32.72%-430M | -21.80%-324M |
Financing cash flow | 677.78%15.7B | 70.15%-2.72B | -956.38%-9.11B | 82.74%-862M | -63.54%-4.99B | 61.64%-3.05B | -30.22%-7.96B | 68.79%-6.11B | -64.26%-19.58B | -120.07%-11.92B |
Net cash flow | ||||||||||
Beginning cash position | 34.57%32.14B | -3.65%23.88B | 17.98%24.79B | -28.19%21.01B | -5.06%29.26B | 2.42%30.82B | 42.14%30.09B | -43.80%21.17B | -9.60%37.67B | 22.13%41.67B |
Current changes in cash | 411.59%34.42B | 486.22%6.73B | -145.15%-1.74B | 149.57%3.86B | -922.73%-7.78B | -314.97%-761M | -96.34%354M | 160.50%9.66B | -201.25%-15.97B | -256.83%-5.3B |
Effect of exchange rate changes | 7.84%1.38B | 52.33%1.28B | 1,133.33%837M | 82.51%-81M | 47.39%-463M | -335.92%-880M | 150.27%373M | -1.23%-742M | -156.34%-733M | -68.80%1.3B |
Cash adjustments other than cash changes | -99.61%1M | 25,500.00%254M | ---1M | ---- | -101.22%-1M | --82M | ---- | ---- | 20,300.00%202M | -200.00%-1M |
End cash Position | 111.38%67.94B | 34.57%32.14B | -3.65%23.88B | 17.98%24.79B | -28.19%21.01B | -5.06%29.26B | 2.42%30.82B | 42.14%30.09B | -43.80%21.17B | -9.60%37.67B |
Free cash flow | 88.54%19.83B | 141.89%10.52B | 230.21%4.35B | -456.67%-3.34B | -115.23%-600M | 38.05%3.94B | -51.49%2.85B | -26.54%5.88B | -39.88%8.01B | -17.05%13.32B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |